Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Stock
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 EGP | +0.49% | -6.76% | +25.45% |
Sales 2024 * | 2.92B 60.91M | Sales 2025 * | 3.21B 67.08M | Capitalization | 3.09B 64.41M |
---|---|---|---|---|---|
Net income 2024 * | 361M 7.54M | Net income 2025 * | 485M 10.13M | EV / Sales 2024 * | 1.42 x |
Net Debt 2024 * | 1.07B 22.27M | Net Debt 2025 * | 766M 15.99M | EV / Sales 2025 * | 1.2 x |
P/E ratio 2024 * |
6.97
x | P/E ratio 2025 * |
6.34
x | Employees | - |
Yield 2024 * |
3.41% | Yield 2025 * |
5.13% | Free-Float | 50.28% |
1 day | -4.19% | ||
1 week | -17.93% | ||
Current month | -20.77% | ||
1 month | -23.70% | ||
3 months | +3.00% | ||
6 months | +29.56% | ||
Current year | +24.85% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 10-12-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 18-12-31 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 19-12-31 |
Director/Board Member | 65 | 18-12-31 | |
Director/Board Member | - | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 2.07 | +0.49% | 5,215,029 |
24-05-01 | 2.06 | 0.00% | 3,548,009 |
24-04-30 | 2.06 | -4.19% | 7,846,718 |
24-04-29 | 2.15 | +0.47% | 4,220,854 |
24-04-28 | 2.14 | -3.60% | 9,835,275 |
End-of-day quote Egyptian Exchange, April 29, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.85% | 64.35M | |
+29.68% | 681B | |
+19.60% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.02% | 235B | |
+4.36% | 199B | |
-11.98% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- RMDA Stock